Institutional investors purchased a net $1.6 million shares of PTN during the quarter ended December 2017 and now own 10.38% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACADIAN ASSET MANAGEMENT LLC Bought 2.1 Million shares of Palatin Technologies Inc